XXXII PTHiT | SYMPOZJUM PREZYDENCKIE EHA-PTHiT - Relacje cyfrowe

Platelet transfusion refractoriness: How to manage

France Pirenne

Platelet transfusion refractoriness: How to manage
Characteristics of hepatitis E virus (HEV) infections in blood donors in Mazovia based on the results of confirmatory testing – preliminary conclusions for transfusion safety

Ewa Sulkowska

Characteristics of hepatitis E virus (HEV) infections in blood donors in Mazovia based on the results of confirmatory testing – preliminary conclusions for transfusion safety
Precision medicine in AML: Genetics guiding treatment

Konstanze Döhner

Precision medicine in AML: Genetics guiding treatment
MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

Krzysztof Jamroziak

MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)
Personalized haemophilia treatment, challenges for the coming years

Karina Meijer

Personalized haemophilia treatment, challenges for the coming years
Molecular characterization of qualitative and quantitative congenital fibrinogen disorders

Jerzy Windyga

Molecular characterization of qualitative and quantitative congenital fibrinogen disorders